Key points are not available for this paper at this time.
This case report describes a patient with immune checkpoint inhibitor–associated bullous pemphigoid and preexisting anti-BP180–C-terminus antibodies.
Koga et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: